Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir vs Efavirenz in HIV
NCT00013897Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2001
- Primary completion
- Apr 2003
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Feb 2001; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00013897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00013897.